Medical Robots Market
Request Customisation
Speak to Analyst
Get Free Sample Pages
Medical Robots Market by Product & Services (Instruments & Accessories, Robotic Systems, Services), Type (Surgical (General, Gynecological, Urological, Knee & Hip, Spine), Rehabilitation, Hospital, Pharmacy), End User, and Region - Global Forecasts to 2031
MEDICAL ROBOTS MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global medical robots market is projected to grow from USD 20.61 billion in 2026 to USD 41.70 billion by 2031, at a CAGR of 15.1% during the forecast period. The market was valued at USD 17.95 billion in 2025. Revenue growth in the medical robots market is increasingly shifting toward advanced robotic platforms that enhance precision, automation, and efficiency across surgical, therapeutic, and healthcare workflow applications. The adoption of Artificial Intelligence-enabled surgical planning, image-guided navigation, robotic arms, automated medication dispensing systems, and rehabilitation exoskeletons is creating new revenue opportunities by expanding the role of robotics beyond traditional procedures. These technology advancements are supporting the transition toward minimally invasive care, reducing procedural variability, improving patient safety, and optimizing clinical workflows. Furthermore, the rising chronic disease burden, growing geriatric population, increasing surgical volumes, and the need to reduce medication errors are accelerating the adoption of medical robots globally.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Base Year Market Size (2025): USD 17.95 Billion
Current Market Size (2026): USD 20.61 Billion
Forecast Market Size (2031): USD 41.70 Billion
CAGR (2026–2031): 15.1% -
SEGMENT LEADERSHIP:
Regional Leader: North America accounted for the highest share of the global medical robots market in 2025.
Product & Services Leader: The instruments & accessories segment accounted for the largest share of the medical robots market in 2025.
Type Leader: The surgical robotic systems segment is estimated to account for the largest market share during the forecast period.
End User Leader: The hospitals & clinics segment is estimated to account for the highest share of the surgical robots market during the forecast period. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Intuitive Surgical and Medtronic Plc were recognized as star players due to their established strong product portfolio.
ARxIUM and Relay Robotics, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The global medical robots market is witnessing steady growth, driven by several key factors. The rising burden of chronic diseases, aging populations, increasing surgical volumes, and growing demand for minimally invasive procedures are accelerating the adoption of robotic-assisted technologies across healthcare settings. In addition, advancements in surgical robotics, rehabilitation robots, hospital automation, pharmacy robotics, and non-invasive radiosurgery systems, along with innovations in AI-enabled planning, image-guided navigation, workflow automation, and real-time data integration, are improving procedural precision, operational efficiency, patient safety, and scalability of robotic healthcare delivery worldwide.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The medical robots market is undergoing major shifts driven by rapid technological advancement, expanding clinical applications, and increasing pressure on healthcare systems to improve efficiency, safety, and patient outcomes. The integration of robotics with AI-enabled planning, advanced imaging, navigation systems, automation software, and real-time data analytics is enhancing precision across surgical procedures, rehabilitation therapy, radiosurgery, pharmacy automation, and hospital workflow management. The emergence of compact, modular, and application-specific robotic systems is expanding adoption beyond large tertiary hospitals to ambulatory surgery centers, rehabilitation facilities, pharmacies, and specialty care settings. Advancements in robotic-assisted surgery, medication dispensing automation, rehabilitation exoskeletons, autonomous hospital logistics, and non-invasive radiosurgery are helping providers reduce procedural variability, minimize medication errors, improve recovery outcomes, and optimize staff productivity, while competitive disruption is pushing the market toward service-based models, recurring consumables, software-enabled platforms, remote support, and training ecosystems.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing geriatric population with chronic diseases
-
Technological advancements in medical robotics
Level
-
High cost of medical robotic systems
-
Stringent regulatory requirements and delays in product approvals
Level
-
High growth opportunities in emerging economies
-
Increased use of robotics in novel applications
Level
-
Need to ensure patient and provider acceptance
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Technological advancements in medical robotics
Technological advancements in medical robotics are a key driver of market growth, as they are improving procedural precision, clinical efficiency, safety, and workflow automation across healthcare settings. Innovations such as AI-enabled surgical planning, image-guided navigation, advanced robotic arms, real-time data integration, haptic feedback, compact robotic platforms, automated medication dispensing, and rehabilitation exoskeletons are expanding the use of robots beyond conventional surgical applications. These technologies help hospitals and care providers reduce procedural variability, support minimally invasive interventions, improve medication accuracy, and deliver more consistent rehabilitation outcomes. For instance, in 2025, Medtronic received U.S. FDA clearance for its Hugo robotic-assisted surgery system for minimally invasive urologic procedures, including prostatectomy, nephrectomy, and cystectomy, reflecting continued innovation and regulatory progress in surgical robotics.
Restraint: High cost of medical robotic systems
The high cost of medical robotic systems is a major restraint limiting broader market adoption, particularly across small hospitals, ambulatory surgery centers, rehabilitation facilities, and healthcare providers in cost-sensitive markets. Medical robotic platforms often involve high upfront capital investment, along with recurring expenses related to instruments & accessories, maintenance contracts, software upgrades, staff training, and infrastructure modifications. For instance, robotic surgical platforms such as Intuitive Surgical’s da Vinci system and Stryker’s Mako robotic-arm-assisted platform require significant capital investment, in addition to recurring costs for maintenance, procedure-specific instruments, accessories, disposables, training, and software support. These high total ownership costs can make it difficult for smaller facilities to justify adoption, especially when procedure volumes are insufficient to generate a strong return on investment. As a result, despite the clinical benefits of robotic-assisted care, affordability challenges continue to restrict faster penetration of medical robots across emerging economies and lower-volume healthcare settings.
Opportunity: Increased use of robotics in novel applications
The growing use of robotics in novel applications is driving significant growth opportunities in the medical robots market, as healthcare providers increasingly deploy robots beyond traditional surgical settings. Medical robots are now being adopted in areas such as hospital logistics, pharmacy automation, rehabilitation therapy, radiosurgery, patient support, and medication delivery, enabling providers to improve workflow efficiency, reduce staff burden, minimize errors, and enhance care delivery. For example, in 2025, Swisslog Healthcare partnered with Diligent Robotics to offer Moxi autonomous delivery robots for hospital “last-mile” logistics, supporting tasks such as medication, lab sample, and supply delivery across healthcare facilities. Diligent Robotics has reported that Moxi has already been deployed in more than 25 U.S. hospitals and has completed over one million deliveries, highlighting the growing role of robotics in non-surgical healthcare applications.
Challenge: Need to ensure patient and provider acceptance
Need to ensure patient and provider acceptance remains a key challenge in the medical robots market, as successful adoption depends not only on technological performance but also on trust, usability, training, and perceived clinical value. Patients may have concerns regarding safety, reliability, outcomes, and the extent of human control in robot-assisted procedures, while healthcare providers may face challenges related to learning curves, workflow changes, operating room coordination, and confidence in using robotic platforms. Adoption is therefore closely linked to surgeon training, clinical evidence, patient education, and the ability of robotic systems to integrate smoothly into existing care pathways. For example, Intuitive offers structured da Vinci learning pathways for surgeons, residents, fellows, and operating room care teams, reflecting the importance of training and confidence-building in robotic-assisted surgery adoption. As medical robots expand into surgery, rehabilitation, pharmacy automation, and hospital logistics, building acceptance among both patients and providers will remain critical for wider market penetration
MEDICAL ROBOTS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Surgical robotic systems and precision instruments designed for minimally invasive procedures across urology, gynecology, thoracic, and general surgery | Equipped with 3D visualization, multi-jointed instruments, and enhanced ergonomics to support highly controlled surgical maneuvers | Enhance surgical precision and dexterity, reduce tissue trauma and complications, support faster patient recovery, and improve consistency and reproducibility in complex minimally invasive procedures |
 |
Orthopedic robotic platform that combines CT-based planning with robotic arm guidance for knee and hip arthroplasty | Enables surgeons to execute personalized implant alignment and bone preparation based on patient-specific anatomy | Improve accuracy of implant positioning, enhance joint stability and alignment, reduce post-operative variability, and support long-term functional outcomes in joint replacement surgeries |
 |
Robotic guidance, navigation, and planning system used primarily in spine surgery | Integrates 3D planning, AI-enhanced imaging, and precise robotic guidance to support accurate screw placement and complex spinal corrections | Increase accuracy in spinal instrumentation, reduce intraoperative deviations, improve surgeon control in high-risk procedures, and enhance overall safety and predictability in spine surgeries |
 |
Compact, handheld robotic-assisted platform designed for partial and total knee arthroplasty | Uses real-time intraoperative mapping to help surgeons achieve precise ligament balancing and bone reshaping without requiring preoperative CT scans | Support personalized knee reconstruction, improve precision in bone preparation, reduce variability in soft-tissue balancing, and enhance workflow efficiency for outpatient and ASC environments |
 |
Multi-specialty robotic platforms that combine data analytics, navigation, and robotic guidance to optimize knee and hip arthroplasty as well as brain surgeries | Provide real-time anatomical data for personalized surgical execution | Increase accuracy of implant alignment, enhance surgical decision-making through real-time data, reduce complication risks, and standardize outcomes across orthopedic and neurosurgical procedures |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The medical robots market operates within a broad and increasingly integrated ecosystem that includes robotic system manufacturers, healthcare providers, regulatory authorities, technology suppliers, software developers, training organizations, and providers of instruments, accessories, and maintenance services. Leading companies such as Intuitive Surgical, Stryker, Medtronic, Zimmer Biomet, Smith+Nephew, BD, Omnicell, Accuray, CMR Surgical, DIH Medical, and Cyberdyne develop robotic platforms and automation solutions across surgical robotics, rehabilitation robotics, pharmacy automation, hospital logistics, and non-invasive radiosurgery. Supporting components, including robotic arms, end-effectors, surgical instruments, disposable accessories, imaging and navigation systems, sensors, AI-enabled software modules, medication dispensing units, and service contracts, are critical to ensuring precision, safety, workflow efficiency, and system reliability across healthcare settings. Healthcare providers, including hospitals, ambulatory surgery centers, pharmacies, rehabilitation centers, and specialty clinics, drive adoption based on clinical demand, procedural efficiency, patient outcomes, medication safety, and operational productivity. Regulatory bodies play a central role in establishing safety, performance, clinical validation, cybersecurity, and interoperability requirements, while training institutions and service providers support user adoption, skill development, and long-term utilization of medical robotic systems.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Medical Robots Market, By Product & Service
Product & Services Leader: The instruments & accessories segment accounted for the largest share of the medical robots market in 2025, driven by the recurring demand for consumables, disposable components, and procedure-specific instruments required for robotic-assisted interventions. Based on products & services, the medical robots market is segmented into robotic systems, instruments & accessories, and services. The robotic systems segment is projected to witness the highest growth rate during the forecast period, supported by the increasing deployment of robotic platforms across both clinical and operational healthcare workflows. Growth in this segment is being driven by the need to improve procedural standardization, reduce human error, enhance treatment consistency, and address workforce limitations across hospitals and specialty care settings. The rising adoption of procedure-specific robotic platforms, compact systems for outpatient care, rehabilitation robots, pharmacy automation systems, and robotic radiosurgery platforms is further expanding the application base of medical robots. In addition, continued investments in next-generation robotic hardware, software-enabled control systems, remote monitoring, and integrated workflow solutions are expected to accelerate demand for robotic systems across the healthcare ecosystem.
Medical Robots Market, By Type
Type Leader: The surgical robotic systems segment is estimated to account for the largest share of the medical robots market during the forecast period, supported by the increasing adoption of robotic-assisted minimally invasive procedures across multiple surgical specialties. Based on type, the medical robots market is segmented into surgical robotic systems, rehabilitation robotic systems, radiosurgery robotic systems, hospital robotic systems, and pharmacy robotic systems. The hospital robotic systems segment is expected to register the highest CAGR during the forecast period, driven by the increasing adoption of automation across hospital workflows, including diagnostics, patient support, internal logistics, disinfection, medication transport, and clinical assistance. The growing use of diagnostic robots and imaging-integrated robotic platforms is further supporting segment growth, as hospitals increasingly focus on improving diagnostic accuracy, reducing manual workload, and enhancing workflow efficiency. In addition, rising pressure on hospitals to address staff shortages, improve patient throughput, reduce infection risks, and optimize operational productivity is accelerating the deployment of robotic systems across hospital environments. The expansion of smart hospitals and digitally connected care infrastructure is expected to further strengthen demand for hospital robotic systems over the forecast period.
Medical Robots Market, By End User
End User Leader: The hospitals & clinics segment is estimated to account for the largest share of the medical robots market during the forecast period, driven by the high volume of robotic-assisted procedures, advanced healthcare infrastructure, and continued investments in robotic technologies across multidisciplinary clinical settings. Based on end user, the medical robots market is segmented into hospitals & clinics, ambulatory surgery centers, pharmacies, rehabilitation centers, and other end users. The ambulatory surgery centers segment is projected to witness the highest growth rate during the forecast period, supported by the growing preference for outpatient surgical care and the increasing availability of robotic platforms suitable for focused, high-volume procedures. ASCs are increasingly adopting robotic-assisted technologies to improve procedural consistency, enhance surgeon control, and support faster patient turnover in cost-sensitive care settings. The segment is also benefiting from the development of smaller, more flexible, and procedure-specific robotic systems that require less infrastructure than traditional hospital-based platforms. In addition, rising investments in advanced ambulatory care infrastructure and the growing emphasis on same-day discharge models are expected to further support the adoption of medical robots across ASCs.
REGION
Asia Pacific to be fastest-growing region in global medical robots market during forecast period
The Asia Pacific region is expected to witness the highest CAGR in the medical robots market during the forecast period. The rising prevalence of chronic diseases, increasing surgical volumes, growing geriatric population, and expanding demand for minimally invasive and precision-based procedures are driving market growth across the region. Rapid adoption of advanced technologies such as surgical robots, rehabilitation robots, pharmacy automation systems, hospital robotic systems, and robotic radiosurgery platforms is further supporting market expansion. The region’s large patient pool, rising healthcare expenditure, improving hospital infrastructure, and growing disposable incomes are increasing the demand for advanced robotic healthcare solutions. Moreover, government initiatives to strengthen healthcare systems, expansion of private hospital networks, and increasing digitalization of healthcare facilities are anticipated to accelerate the growth of the Asia Pacific medical robots market.
North America accounted for the largest share of the global medical robots market in 2025
North America accounted for the highest share of the global medical robots market in 2025, supported by advanced healthcare infrastructure, high adoption of robotic-assisted procedures, strong presence of leading medical robotics companies, and significant investments in healthcare technology innovation. The US represents the major contributor to regional growth due to increasing adoption of surgical robotic systems, growing demand for minimally invasive procedures, favorable reimbursement frameworks, and continuous advancements in robotic platforms. The region’s strong research and development ecosystem and early adoption of next-generation healthcare technologies further support its leading position in the medical robots market.
MEDICAL ROBOTS MARKET: COMPANY EVALUATION MATRIX
In the medical robots market matrix, Intuitive Surgical (Star) leads with its unmatched global installed base, strong brand recognition, and comprehensive da Vinci platform ecosystem that spans instruments, accessories, training, and digital surgery solutions. CMR Surgical (Emerging Leader) is rapidly gaining traction with its versatile and cost-effective Versius robotic system, which offers modular design, improved maneuverability, and greater accessibility for hospitals and ambulatory centers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Base Year | 2025 |
| Base Year Market Size (2025) | USD 17.95 Billion |
| Current Market Size (2026) | USD 20.61 Billion |
| Projected Market Size (2031) | USD 41.70 Billion |
| Growth Rate | CAGR of 15.1% from 2026–2031 |
| Forecast Period | 2026–2031 |
| Years Considered | 2024–2031 |
| Units Considered | Value (USD Million), Volume (Million Units) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Product & Services, Type, End User, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Report Code | MD 2257 |
| Published | 2026-06-16 |
| Prepared By | MarketsandMarkets™ Healthcare Research Team |
| Last Reviewed | 2026-07-24 |
WHAT IS IN IT FOR YOU: MEDICAL ROBOTS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Volume Analysis | Market assessment by volume (units) for surgical robots used in medical settings |
|
| Company Information |
|
Insights on revenue shifts towards emerging therapeutic applications and device innovations |
RECENT DEVELOPMENTS
- October 2025 : Zimmer Biomet (US) completed the acquisition of Monogram Technologies, Inc. (US), an Artificial Intelligence-driven orthopedic robotics company, to expand its robotics and navigation portfolio and strengthen its capabilities in robot-assisted orthopedic procedures.
- October 2024 : CMR Surgical (UK) received US Food and Drug Administration (FDA) De Novo authorization for its Versius Surgical System for use in cholecystectomy procedures, expanding the company's presence in the US robotic surgery market.
- June 2024 : Medtronic completed a USD 8 million asset purchase and licensing agreement with Titan Medical to expand its intellectual property portfolio in soft-tissue robotics. The acquisition of key technologies and design concepts strengthens the development pipeline for the Hugo RAS system and supports continued innovation in multi-specialty robotic surgery.
- March 2024 : The US Food and Drug Administration (FDA) granted 510(k) clearance for Intuitive's da Vinci 5 system, introducing the company's next-generation robotic surgery platform with advancements in instrumentation, imaging, system responsiveness, and surgeon ergonomics to further strengthen its leadership in minimally invasive soft-tissue surgery.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the medical robots market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the medical robots market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Ambulatory surgery centers (ASCs), Minimally Invasive Robotic Association (MIRA), Clinical Robotic Surgery Association (CRSA), American Association of Healthcare Administrative Management (AAHAM), Centers for Disease Control and Prevention (CDC), American Medical Group Association (AMGA), Centers for Medicare & Medicaid Services (CMS), American Hospital Association (AHA), Expert Interviews, and MarketsandMarkets Analysis.
Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the medical robots market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global medical robots market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
Breakdown of Primary Interviews
Notes: C-level primaries include CEOs, CFOs, COOs, and VPs.
Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the global medical robots market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- Key players in the global medical robots market were identified through secondary research, and their global market shares were determined through primary and secondary research
- The research methodology included the study of the annual and quarterly financial reports and regulatory filings, data books of major market players, and interviews with industry experts for detailed market insights.
- All percentage shares, splits, and breakdowns for the global medical robots market were determined by using secondary sources and verified through primary sources.
- All key macro indicators affecting the revenue growth of market segments and subsegments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get validated and verified quantitative and qualitative data.
- The gathered market data was consolidated and added with detailed inputs and analysis, and presented in this report.
Medical Robots Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the medical robots market was split into segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Medical robots are advanced technological systems designed to assist healthcare professionals in various medical procedures, tasks, and interventions. These robots are equipped with sensors, actuators, and sophisticated control systems that enable them to perform specific functions autonomously or under the guidance of human operators.
Medical robots are utilized across different domains within healthcare, including surgery, rehabilitation, diagnostics, pharmacy automation, and patient care. They play a crucial role in enhancing precision, efficiency, and safety in medical interventions, contributing to improved patient outcomes, reduced complications, and enhanced healthcare delivery.
Key Stakeholders
- Manufacturers of medical robots
- Suppliers and distributors of medical robots
- Third-party refurbishers/suppliers
- Clinical settings
- Educational institutions
- Group purchasing organizations (GPOs)
- Academic medical centers and universities
- Corporate entities
- Community centers
- Government institutes
- Market research & consulting firms
- Contract manufacturing organizations (CMOs)
- Venture capitalists & investors
Report Objectives
- To define, describe, and forecast the medical robots market by product & service, type, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall medical robots market
-
To analyze the opportunities in the market for stakeholders and provide details of
the competitive landscape for market leaders - To profile the key players in the market and comprehensively analyze their market shares and core competencies2
-
To forecast the size of the market segments with respect to five main regions:
North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa - To track and analyze competitive developments such as product launches & approvals, acquisitions, expansions, partnerships, deployments, agreements, and collaborations in the overall medical robots market
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Europe medical robots market into Switzerland, Russia, and others
- Further breakdown of the Rest of Asia Pacific medical robots market into South Korea, Singapore, and others
Key Questions Addressed by the Report
What is the projected growth outlook for the global medical robots market through 2031?
The global medical robots market is projected to grow from USD 20.61 billion in 2026 to USD 41.70 billion by 2031, registering a CAGR of 15.1% during the forecast period. The market was valued at USD 17.95 billion in 2025, driven by increasing adoption of robotic technologies across surgical, rehabilitation, hospital, and pharmacy applications.
Which product and services segment dominated the medical robots market in 2025?
The instruments & accessories segment accounted for the largest share of the medical robots market by product and services in 2025. This segment includes essential components that support the functioning and adoption of robotic healthcare systems.
Which type of medical robots is expected to hold the largest market share during the forecast period?
The surgical robotic systems segment is estimated to account for the largest market share of the medical robots market during the forecast period. Surgical robotic systems are increasingly adopted across procedures including general, gynecological, urological, knee & hip, and spine surgeries.
Which region led the global medical robots market in 2025?
North America accounted for the highest share of the global medical robots market in 2025. The region maintained its leading position due to strong adoption of robotic healthcare technologies and the presence of leading medical robotics companies.
Which end user segment is expected to dominate the surgical robots market during the forecast period?
The hospitals & clinics segment is estimated to account for the highest share of the surgical robots market during the forecast period. Hospitals and clinics represent key healthcare settings for the adoption of robotic-assisted surgical systems.
What are the major application areas covered in the medical robots market?
The medical robots market covers multiple application areas including surgical robots, rehabilitation robots, hospital robots, and pharmacy robots. The surgical robotics segment includes general, gynecological, urological, knee & hip, and spine procedures.
Who are the key players operating in the global medical robots market?
Key players profiled in the medical robots market include Intuitive Surgical, Stryker, Medtronic, Smith+Nephew, Zimmer Biomet, Siemens Healthineers AG, Renishaw Plc, Johnson & Johnson, Globus Medical, Inc., and CMR Surgical.
Which companies are recognized as star players and emerging companies in the medical robots market?
Intuitive Surgical and Medtronic Plc were recognized as star players due to their established strong product portfolios. ARxIUM and Relay Robotics, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas and demonstrating potential as emerging market leaders.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Medical Robots Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
- Canada Medical Robots Market
- US Medical Robots Market
- Germany Medical Robots Market
- UK Medical Robots Market
- France Medical Robots Market
- Italy Medical Robots Market
- Spain Medical Robots Market
- Japan Medical Robots Market
- China Medical Robots Market
- India Medical Robots Market
- Brazil Medical Robots Market
- Mexico Medical Robots Market
Growth opportunities and latent adjacency in Medical Robots Market